Paper3753554
Comparative pharmacokinetics and metabolism of doxorubicin and 4-demethoxy-4'-O-methyldoxorubicin in tumor-bearing mice.
Formelli F and 2 others. Cancer Chemother Pharmacol, 1986. Cited by 19 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Comparative pharmacokinetics and metabolism of doxorubicin and 4-demethoxy-4'-O-methyldoxorubicin in tumor-bearing mice. Papers, record 3753554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3753554
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparative pharmacokinetics and metabolism of doxorubicin and 4-demethoxy-4'-O-methyldoxorubicin in tumor-bearing mice.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Doxorubicin | Major topic |
| Animals | |
| Carcinoma | |
| Colonic Neoplasms | |
| Female | |
| Liver | |
| Metabolic Clearance Rate | |
| Mice | |
| Tissue Distribution |
Source PubMed
References12
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7296751 | Fluorescence assays and pharmacokinetic studies of 4'-deoxydoxorubicin and doxorubicin in organs of mice bearing solid tumors. | Cancer Chemother Pharmacol | 1981 | https://conductscience.org/library/papers/7296751 | PubMed |
| 2 | 6244090 | Clinical pharmacokinetics of adriamycin in hepatoma patients with cirrhosis. | Cancer Res | 1980 | https://conductscience.org/library/papers/6244090 | PubMed |
| 3 | 294954 | Fluorescence assay of tissue distribution of 4-demethoxydaunorubicin and 4-demethoxydoxorubicin in mice bearing solid tumors. | Cancer Chemother Pharmacol | 1979 | https://conductscience.org/library/papers/294954 | PubMed |
| 4 | 6459335 | Rapid high-performance liquid chromatographic assay for the anthracyclines daunorubicin and 7-con-O-methylnogarol in plasma. | J Chromatogr | 1981 | https://conductscience.org/library/papers/6459335 | PubMed |
| 5 | 4417723 | Adriamycin and daunorubicin disposition in the rabbit. | J Pharmacol Exp Ther | 1974 | https://conductscience.org/library/papers/4417723 | PubMed |
| 6 | 4715566 | A fluorometric assay for daunomycin and adriamycin in animal tissues. | Biochem Med | 1973 | https://conductscience.org/library/papers/4715566 | PubMed |
| 7 | 647696 | Synthesis and antitumor activity of 4-demethoxyadriamycin and 4-demethoxy-4' -epiadriamycin. | Cancer Treat Rep | 1978 | https://conductscience.org/library/papers/647696 | PubMed |
| 8 | 6930988 | Determination of daunorubicin and its main metabolites in plasma, urine and leukaemic cells in patients with acute myeloblastic leukaemia. | Cancer Lett | 1980 | https://conductscience.org/library/papers/6930988 | PubMed |
| 9 | 884924 | Bilary disposition of adriamycin. | Clin Pharmacol Ther | 1977 | https://conductscience.org/library/papers/884924 | PubMed |
| 10 | 119583 | Comparative metabolism and excretion of adriamycin in man, monkey, and rat. | Cancer Chemother Pharmacol | 1979 | https://conductscience.org/library/papers/119583 | PubMed |
| 11 | 6575865 | Synthesis, antitumor activity, and cardiac toxicity of new 4-demethoxyanthracyclines. | Cancer Treat Rep | 1983 | https://conductscience.org/library/papers/6575865 | PubMed |
| 12 | 7090422 | Body residue and metabolism of adriamycin and daunorubicin in control and phenobarbital-pretreated mice. | Xenobiotica | 1982 | https://conductscience.org/library/papers/7090422 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 29987398 | A Multiscale Physiologically-Based Pharmacokinetic Model for Doxorubicin to Explore its Mechanisms of Cytotoxicity and Cardiotoxicity in Human Physiological Contexts. | Pharm Res | 2018 | https://conductscience.org/library/papers/29987398 | PubMed |
| 8004751 | Quantitation of cell-associated doxorubicin by high-performance liquid chromatography after enzymatic desequestration. | Cancer Chemother Pharmacol | 1994 | https://conductscience.org/library/papers/8004751 | PubMed |
| 3741758 | In vivo characterization of a doxorubicin resistant B16 melanoma cell line. | Br J Cancer | 1986 | https://conductscience.org/library/papers/3741758 | PubMed |
| 3370742 | Effect of verapamil on doxorubicin activity and pharmacokinetics in mice bearing resistant and sensitive solid tumors. | Cancer Chemother Pharmacol | 1988 | https://conductscience.org/library/papers/3370742 | PubMed |
| 3358904 | Doxorubicin cellular pharmacokinetics and DNA breakage in a multi-drug resistant B16 melanoma cell line. | Br J Cancer | 1988 | https://conductscience.org/library/papers/3358904 | PubMed |
| 2691361 | Streptomycetes producing daunomycin and related compounds: do we know enough about them after 25 years? | Folia Microbiol (Praha) | 1989 | https://conductscience.org/library/papers/2691361 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3753554
GET https://conductscience.org/api/papers/v1/3753554/authors